Related references
Note: Only part of the references are listed.Selective Regulation of Osteoblastic OPG and RANKL by Dehydroepiandrosterone Through Activation of the Estrogen Receptor β-mediated MAPK Signaling Pathway
Y. -D. Wang et al.
HORMONE AND METABOLIC RESEARCH (2012)
Brain-derived neurotrophic factor is a potential osteoclast stimulating factor in multiple myeloma
Chun-Yan Sun et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells
Hiroyuki Fujikawa et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Inhibition of BDNF in Multiple Myeloma Blocks Osteoclastogenesis via Down-Regulated Stroma-Derived RANKL Expression Both In Vitro and In Vivo
Li-Sha Ai et al.
PLOS ONE (2012)
Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer
Neill Patani et al.
CANCER CELL INTERNATIONAL (2011)
Glucocorticoid suppresses BDNF-stimulated MAPK/ERK pathway via inhibiting interaction of Shp2 with TrkB
Emi Kumamaru et al.
FEBS LETTERS (2011)
Lentiviral shRNA silencing of BDNF inhibits in vivo multiple myeloma growth and angiogenesis via down-regulated stroma-derived VEGF expression in the bone marrow milieu
Lu Zhang et al.
CANCER SCIENCE (2010)
Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro
Johannes Pfeilschifter et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Neurotrophins Regulate Bone Marrow Stromal Cell IL-6 Expression through the MAPK Pathway
Fariba Rezaee et al.
PLOS ONE (2010)
Regulation of local translation at the synapse by BDNF
Ana Rita Santos et al.
PROGRESS IN NEUROBIOLOGY (2010)
Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome
Christy W. H. Au et al.
CANCER LETTERS (2009)
The pathogenesis of the bone disease of multiple myeloma
Claire M. Edwards et al.
BONE (2008)
Role of endogenous brain-derived neurotrophic factor and sortilin in B cell survival
Anne-Laure Fauchais et al.
JOURNAL OF IMMUNOLOGY (2008)
Macrophage inflammatory protein-1α (MIP-1α) enhances a receptor activator of nuclear factor κB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways
Masanobu Tsubaki et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
Interaction of FGF-2 with IGF-1 and BDNF in stimulating Akt, ERK, and neuronal survival in hippocampal cultures
Nadine N. Johnson-Farley et al.
BRAIN RESEARCH (2007)
Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: A role for vascular endothelial cell growth factor and osteopontin
Ybichi Tanaka et al.
CLINICAL CANCER RESEARCH (2007)
Brain-derived neurotrophic factor promotes growth and migration of multiple myeloma cells
Yu Hu et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Differential gene expression pattern of neurotrophins and their receptors during neuronal differentiation of rat bone marrow stromal cells
MM Yaghoobi et al.
NEUROSCIENCE LETTERS (2006)
The neurotrophic receptor TrkB: a drug target in anti-cancer therapy?
CJ Desmet et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Annexin II stimulates RANKL expression through MAPK
FH Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival
RN Pearse et al.
BLOOD (2005)
Elevated serum levels of stromal-derived factor-1α are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients
ACW Zannettino et al.
CANCER RESEARCH (2005)
IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells
JW Lee et al.
BLOOD (2004)
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology
KT Steeve et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Soluble receptor activator of nuclear factor κB ligand-osteoprotegerin ratio predicts survival in multiple myeloma:: proposal for a novel prognostic index
E Terpos et al.
BLOOD (2003)
Efficient lentiviral vectors for short hairpin RNA delivery into human cells
DS An et al.
HUMAN GENE THERAPY (2003)
Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes:: a potential role in multiple myeloma bone disease
N Giuliani et al.
BLOOD (2002)
Immunocytochemistry reveals RANKL expression of myeloma cells
O Sezer et al.
BLOOD (2002)
RANK (receptor activator of nuclear factor-κB) and RANKL expression in multiple myeloma
S Roux et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment
N Giuliani et al.
BLOOD (2001)
Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression
RN Pearse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Autocrine expression of neurotrophins and their receptors in prostate cancer
F Satoh et al.
INTERNATIONAL JOURNAL OF UROLOGY (2001)
BDNF dependence in neuroblastoma
X Feng et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Share Paper
